These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 39227723)

  • 1. Association of elevated baseline bilirubin caused by preadmission statin use with cardiovascular prognosis in patients undergoing elective percutaneous coronary intervention.
    Zhu Y; Li D; Li J; Wang Y; Chen Z; Lv Q; Fu G; Zhang W
    Sci Rep; 2024 Sep; 14(1):20451. PubMed ID: 39227723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bilirubin on perioperative myocardial infarction and its long-term prognosis in patients undergoing percutaneous coronary intervention.
    Li Y; Li DB; Zhao LD; Lv QB; Wang Y; Ren YF; Zhang WB
    World J Clin Cases; 2022 Feb; 10(6):1775-1786. PubMed ID: 35317137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention.
    Suwa S; Ogita M; Miyauchi K; Sonoda T; Konishi H; Tsuboi S; Wada H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Daida H
    J Atheroscler Thromb; 2017 Nov; 24(11):1125-1131. PubMed ID: 28321012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive values of bilirubin for in-hospital adverse events in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
    Ying C; Liu CF; Guo DQ; Du ZR; Wei YJ
    Clinics (Sao Paulo); 2023; 78():100306. PubMed ID: 37949037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of gender difference on long-term outcomes of percutaneous coronary intervention for coronary artery disease in patients under statin treatment.
    Wada H; Ogita M; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Tamura H; Okazaki S; Isoda K; Suwa S; Daida H
    Heart Vessels; 2017 Jan; 32(1):16-21. PubMed ID: 27107767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of lipoprotein (a) on long-term clinical outcomes in diabetic patients on statin treatment after percutaneous coronary intervention.
    Takahashi N; Dohi T; Funamizu T; Endo H; Wada H; Doi S; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Shimada K
    J Cardiol; 2020 Jul; 76(1):25-29. PubMed ID: 32089480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease.
    Zhu L; Fang Y; Gao B; Jin X; Zheng J; He Y; Huang J
    BMC Cardiovasc Disord; 2022 Nov; 22(1):474. PubMed ID: 36348286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between statin therapy and long-term clinical outcomes in patients with stable coronary disease undergoing percutaneous coronary intervention.
    Wu HP; Yang FC; Lin HD; Cai CZ; Chuang MJ; Chiang KF; Lin MJ
    Sci Rep; 2024 Jun; 14(1):12674. PubMed ID: 38830964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Fasting Serum Bilirubin Levels with Clinical Outcomes After Percutaneous Coronary Intervention: A Prospective Study.
    Zhang MM; Gao Y; Zheng YY; Chen Y; Liu F; Ma YT; Xie X
    Cardiovasc Toxicol; 2017 Oct; 17(4):471-477. PubMed ID: 28283905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
    Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the role of high-dose statins administered prior to percutaneous coronary intervention in reducing major adverse cardiac events in patients with coronary artery disease.
    Hao PP; Chen YG; Wang JL; Ji WQ; Xue L; Liu XH; Wang XL; Zhang Y
    Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):496-500. PubMed ID: 19930422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent prognostic effect of high sensitivity C-reactive protein with statin therapy in acute myocardial infarction.
    Kang DO; Park Y; Seo JH; Jeong MH; Chae SC; Ahn TH; Jang WY; Kim W; Park EJ; Choi BG; Na JO; Choi CU; Kim EJ; Rha SW; Park CG; Seo HS;
    J Cardiol; 2019 Jul; 74(1):74-83. PubMed ID: 30745001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
    Perera D; Crake T; Lee V
    Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypocholesterolaemia and mortality in patients with coronary artery disease.
    Ndrepepa G; Holdenrieder S; Cassese S; Xhepa E; Fusaro M; Kastrati A
    Eur J Clin Invest; 2020 Feb; 50(2):e13194. PubMed ID: 31863458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Statin Benefits Patients with Heart Failure Undergoing Percutaneous Coronary Intervention? Findings from the Melbourne Interventional Group Registry.
    Chin KL; Wolfe R; Reid CM; Tonkin A; Hopper I; Brennan A; Andrianopoulos N; Duffy SJ; Clark D; Ajani A; Liew D;
    Cardiovasc Drugs Ther; 2018 Feb; 32(1):57-64. PubMed ID: 29349644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Navarese EP; Kowalewski M; Andreotti F; van Wely M; Camaro C; Kolodziejczak M; Gorny B; Wirianta J; Kubica J; Kelm M; de Boer MJ; Suryapranata H
    Am J Cardiol; 2014 May; 113(10):1753-64. PubMed ID: 24792742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Serum Total Bilirubin after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome.
    Tang C; Qian H; Wang D; Qiao Y; Yan G
    Biomed Res Int; 2019; 2019():5243589. PubMed ID: 31275974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prehospital statin therapy and one-year mortality in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
    Ndrepepa G; King L; Cassese S; Fusaro M; Tada T; Schömig A; Kastrati A
    Eur J Intern Med; 2013 Mar; 24(2):145-50. PubMed ID: 23182629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of High-Dose Statin Pretreatment for Myocardial Perfusion in Patients Receiving Percutaneous Coronary Intervention (PCI): A Meta-Analysis of 15 Randomized Studies.
    Xiao Y; He S; Zhang Z; Feng H; Cui S; Wu J
    Med Sci Monit; 2018 Dec; 24():9166-9176. PubMed ID: 30557296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials.
    Wang L; Peng P; Zhang O; Xu X; Yang S; Zhao Y; Zhou Y
    PLoS One; 2014; 9(12):e113352. PubMed ID: 25473831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.